A more effective seasonal flu vaccine is about to be tested in the US A more effective seasonal flu vaccine is about to be tested in clinical trials across the US. The flu shot was working well early in the season with effectiveness around 47% in February. But this...
Phase 2 trial will enroll approximately 30 patients and evaluate both safety and efficacy – Ziopharm Oncology, Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP) today announced the initiation of a phase 2 clinical trial evaluating Controlled IL-12 (Ad-RTS-hIL-12...
Hope Pharmaceuticals today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a clinical trial application for medical centers in the United Kingdom to participate in the international investigational clinical study that is...
Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases, today announced that the first patient has...
-vTv Therapeutics Inc. (Nasdaq: VTVT) announced today that the first patient has been screened for the phase 2 proof of concept study evaluating the safety and efficacy of azeliragon in patients with mild Alzheimer’s disease and type 2 diabetes. “With positive...
Email
Text